Recce Pharmaceuticals Ltd (RCE.AX)
AUD 0.45
(-3.23%)
AUD 0.45
(-3.23%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 811.19 Thousand AUD | 223.74% |
| 2023 | 250.56 Thousand AUD | 235.15% |
| 2022 | 74.76 Thousand AUD | -41.11% |
| 2021 | 126.94 Thousand AUD | 52.52% |
| 2020 | 83.23 Thousand AUD | -88.71% |
| 2019 | 737.4 Thousand AUD | 25692.51% |
| 2018 | 2859.00 AUD | -98.23% |
| 2017 | 161.28 Thousand AUD | 2211.39% |
| 2016 | 6978.00 AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q4 | 811.19 Thousand AUD | 0.0% |
| 2024 FY | 811.19 Thousand AUD | 223.74% |
| 2024 Q2 | 198.76 Thousand AUD | 0.0% |
| 2023 Q4 | 250.56 Thousand AUD | 0.0% |
| 2023 FY | 250.56 Thousand AUD | 235.15% |
| 2023 Q2 | 127.46 Thousand AUD | 0.0% |
| 2022 Q2 | 131.39 Thousand AUD | 0.0% |
| 2022 FY | 74.76 Thousand AUD | -41.11% |
| 2022 Q4 | 74.76 Thousand AUD | 0.0% |
| 2021 Q4 | 126.94 Thousand AUD | 0.0% |
| 2021 FY | 126.94 Thousand AUD | 52.52% |
| 2021 Q2 | 238.63 Thousand AUD | 0.0% |
| 2020 Q4 | 83.23 Thousand AUD | 0.0% |
| 2020 FY | 83.23 Thousand AUD | -88.71% |
| 2020 Q2 | 158.24 Thousand AUD | 0.0% |
| 2019 Q2 | 456 Thousand AUD | 0.0% |
| 2019 FY | 737.4 Thousand AUD | 25692.51% |
| 2019 Q4 | 737.4 Thousand AUD | 0.0% |
| 2018 Q4 | 2859.00 AUD | 0.0% |
| 2018 FY | 2859.00 AUD | -98.23% |
| 2018 Q2 | 128.94 Thousand AUD | 0.0% |
| 2017 FY | 161.28 Thousand AUD | 2211.39% |
| 2017 Q4 | 161.28 Thousand AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2016 Q4 | 6978.00 AUD | 0.0% |
| 2016 Q2 | 95.58 Thousand AUD | 0.0% |
| 2016 FY | 6978.00 AUD | 0.0% |
| 2015 Q4 | - AUD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| 2015 Q3 | - AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 123.85 Thousand AUD | -554.946% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Zelira Therapeutics Limited | 5.65 Million AUD | 85.652% |
| Biome Australia Limited | 1.3 Million AUD | 37.874% |
| Patrys Limited | - AUD | -Infinity% |
| Orthocell Limited | 689.69 Thousand AUD | -17.616% |
| Imugene Limited | 1.54 Million AUD | 47.561% |
| Noxopharm Limited | - AUD | -Infinity% |
| PYC Therapeutics Limited | 1.11 Million AUD | 27.103% |
| Chimeric Therapeutics Limited | - AUD | -Infinity% |
| Prescient Therapeutics Limited | 330.48 Thousand AUD | -145.454% |
| Proteomics International Laboratories Limited | 316.39 Thousand AUD | -156.385% |
| Cynata Therapeutics Limited | - AUD | -Infinity% |
| CSL Limited | 18.24 Billion AUD | 99.996% |
| Arovella Therapeutics Limited | - AUD | -Infinity% |
| Bio-Gene Technology Limited | - AUD | -Infinity% |
| Clinuvel Pharmaceuticals Limited | 879.78 Thousand AUD | 7.797% |
| Starpharma Holdings Limited | 3.52 Million AUD | 77.007% |
| Nanollose Limited | 42.53 Thousand AUD | -1807.336% |
| Memphasys Limited | 4.41 Million AUD | 81.619% |
| Invex Therapeutics Ltd | - AUD | -Infinity% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Amplia Therapeutics Limited | 1.56 Million AUD | 48.058% |
| Botanix Pharmaceuticals Limited | - AUD | -Infinity% |
| Island Pharmaceuticals Limited | 421.96 Thousand AUD | -92.24% |
| Race Oncology Limited | - AUD | -Infinity% |
| Nyrada Inc. | - AUD | -Infinity% |
| Telix Pharmaceuticals Limited | 17.44 Million AUD | 95.35% |
| Dimerix Limited | 149.68 Thousand AUD | -441.939% |
| PharmAust Limited | - AUD | -Infinity% |
| Immutep Limited | 1.22 Million AUD | 33.957% |
| Clarity Pharmaceuticals Ltd | - AUD | -Infinity% |
| Alterity Therapeutics Limited | 159.04 Thousand AUD | -410.038% |
| BTC Health Limited | - AUD | -Infinity% |
| Acrux Limited | 1.48 Million AUD | 45.448% |
| Neuren Pharmaceuticals Limited | - AUD | -Infinity% |
| Biotron Limited | 7130.00 AUD | -11277.139% |
| Tissue Repair Ltd | - AUD | -Infinity% |
| AdAlta Limited | 2.49 Million AUD | 67.482% |
| Radiopharm Theranostics Limited | - AUD | -Infinity% |
| Hexima Limited | - AUD | -Infinity% |
| AnteoTech Limited | 23.59 Thousand AUD | -3338.411% |
| Paradigm Biopharmaceuticals Limited | 239.33 Thousand AUD | -238.942% |
| Avecho Biotechnology Limited | 175.15 Thousand AUD | -363.138% |
| Actinogen Medical Limited | 319.06 Thousand AUD | -154.237% |
| Immuron Limited | 173.49 Thousand AUD | -367.553% |
| Argenica Therapeutics Limited | - AUD | -Infinity% |